Yahoo! Finance Search - Finance Home - Yahoo! - Help

Friday, March 24 2017 4:12pm ET - U.S. Markets Closed.
Industry Center - Biotechnology
Industry Center > Biotechnology > News
More On This Industry
· Summary
News
·Leaders & Laggards
· Company Index
·Industry Browser
Related Industries
· Diagnostic Substances
· Drug Delivery
· Drug Manufacturers - Major
· Drug Manufacturers - Other
· Drug Related Products
· Drugs - Generic
Top Industries
·Aerospace/Defense - Major Diversified
·Auto Manufacturers - Major
·Biotechnology
·Business Software & Services
·Chemicals - Major Diversified
·Communication Equipment
·Conglomerates
·Diversified Computer Systems
·Diversified Investments
·Drug Manufacturers - Major
·Electric Utilities
·Food - Major Diversified
·Industrial Metals & Minerals
·Major Airlines
·Major Integrated Oil & Gas
·Money Center Banks
·Property & Casualty Insurance
·Semiconductor - Broad Line
·Telecom Services - Domestic
Complete Industry List...
 
Biotechnology News
Latest News
Monday, Mar 20, 2017
·Esperion Gets FDA Nod for Cholesterol Drug Program
at Investopedia - Mon Mar 20
·CFRX: Phase 2 Trial of CF-301 to Initiate in mid-2017
- Mon Mar 20
·Biotechs Remain the Best Place For Stock Picking
at TheStreet.com - Mon Mar 20
·Don't Overlook Ziopharm Oncology
at TheStreet.com - Mon Mar 20
·SHAREHOLDR NOTICE: Khang & Khang LLP Announces Securities Class Action Lawsuit against Galena Biopharma Inc., and Encourages Investors with Losses to Contact the Firm
- Mon Mar 20
·Esperion Therapeutics stock surges 52% after it says the FDA gave its drug program positive feedback
at MarketWatch - Mon Mar 20
·Monday‚Äôs Top Biopharma Movers
- Mon Mar 20
·SHAREHOLDER ALERT: Khang & Khang LLP Announces Securities Class Action Lawsuit against Regulus Therapeutics Inc. and Encourages Investors with Losses to Contact the Firm
- Mon Mar 20
·SHAREHOLDER ALERT: Lundin Law PC Announces Securities Class Action Lawsuit against Aratana Therapeutics, Inc. and Encourages Investors with Losses to Contact the Firm
- Mon Mar 20
·SHAREHOLDER ALERT - Bronstein, Gewirtz & Grossman, LLC Reminds Investors of Class Action Against Regulus Therapeutics Inc. (RGLS) and Lead Plaintiff Deadline - April 3, 2017
- Mon Mar 20
·SHAREHOLDER ALERT - Bronstein, Gewirtz & Grossman, LLC Reminds Investors of Class Action Against Stemline Therapeutics, Inc. (STML) and Lead Plaintiff Deadline: April 4, 2017
- Mon Mar 20
·ANTH INVESTOR ALERT: The Law Offices of Vincent Wong Reminds Investors of a Class Action Involving Anthera Pharmaceuticals, Inc. and a Lead Plaintiff Deadline of April 17, 2017
Business Wire - Mon Mar 20
·Waltham's Cerulean Pharma to cut staff, merge with San Diego biotech
at bizjournals.com - Mon Mar 20
·DEADLINE ALERT: Bronstein, Gewirtz & Grossman, LLC Reminds Investors of Class Action Against Egalet Corporation (EGLT) and Lead Plaintiff Deadline - March 28, 2017
- Mon Mar 20
·SHAREHOLDER NOTICE: Lundin Law PC Announces Securities Class Action Lawsuit against Egalet Corporation and Encourages Investors with Losses to Contact the Firm
- Mon Mar 20
·Jefferies Has 4 Red-Hot Biotech and Pharmaceutical Stocks to Buy Now
- Mon Mar 20
·Biotech Premarket Movers: CytomX, Aevi, Esperion
at TheStreet.com - Mon Mar 20
·Global Blood Therapeutics' Acquisition Value Could Be At Least $3 Billion
- Mon Mar 20
·Today's Research Reports on Stocks to Watch: Geron and Galena Biopharma
- Mon Mar 20
·Leerink Presents: Your 2017 Biopharma Catalyst Tracker
- Mon Mar 20
More Latest News...
  

RSS Feeds

Add headlines to your
personalized My Yahoo Page
( About My Yahoo and RSS )

Biotechnology Headlines
More Finance RSS Feeds


Copyright © 2017 Yahoo! Inc. All rights reserved. Privacy Policy - Terms of Service
Industry information © 2017 Morningstar, Inc. All Rights Reserved. Company information © 2017 Capital IQ All Rights Reserved. Quotes and other information supplied by independent providers identified on the Yahoo Finance partner page. S&P 500 index provided by Comstock. All rights reserved. Top-Ranked Analyst information © 1999-2017, StarMine Corp. All rights reserved. Data and information is provided for informational purposes only, and is not intended for trading purposes. Neither Yahoo nor any of its data or content providers (such as Capital IQ, Morningstar, CSI and exchanges) shall be liable for any errors or delays in the content, or for any actions taken in reliance thereon. By accessing the Yahoo site, a user agrees not to redistribute the information found therein.

Questions or Comments?